| Attribute | Value | Source |
|---|---|---|
| Gene Name | yfiC | |
| Protein Length | 604 amino acids | |
| Expression Hosts | E. coli, Yeast, Baculovirus, Mammalian |
Belongs to the ABC transporter superfamily, which utilizes ATP hydrolysis to drive substrate transport across membranes .
Contains conserved NBD motifs, including Walker A/B sequences and the ABC signature motif .
Classified as an "uncharacterized" transporter due to limited experimental data on substrate specificity or regulatory mechanisms .
Recombinant YfiC is produced via heterologous expression in diverse hosts, with varying yields and post-translational modification capabilities .
| Host System | Advantages | Challenges |
|---|---|---|
| E. coli | High yield, rapid turnaround | Limited post-translational modifications |
| Yeast | Improved folding for eukaryotic proteins | Moderate yield |
| Baculovirus (Insect Cells) | Native-like modifications (e.g., phosphorylation) | Higher cost, complex handling |
| Mammalian Cells | Authentic post-translational processing | Low yield, lengthy protocols |
Typical yields range from 1 mg per production run, depending on host efficiency .
Mammalian systems are preferred for functional studies requiring proper protein folding .
Though uncharacterized, YfiC’s role can be hypothesized based on ABC transporter functions in Bacillus subtilis:
Drug Resistance: Overexpression of exporters may confer resistance to antibiotics or toxic metabolites .
Ion/Peptide Transport: Homologs like ABCB6 (iron transport) and ABCB11 (bile salt transport) suggest roles in metal or organic anion translocation .
Regulatory Functions: Some ABC ATPases modulate translation elongation or stress responses .
Zinc Homeostasis: While YfiC is not directly linked to Zur-regulated genes (e.g., yciC) , ABC transporters in Bacillus subtilis often interact with metallochaperones or stress-response systems .
Genetic Neighborhood: YfiC is not part of a known operon, suggesting it may function as a standalone ATPase or pair with orphan TMDs .
Functional Characterization: No experimental data on substrate binding or transport activity.
Structural Validation: AlphaFold predictions require confirmation via X-ray crystallography or cryo-EM .
Regulatory Mechanisms: Potential interactions with transcription factors like Zur remain unexplored .
KEGG: bsu:BSU08220
STRING: 224308.Bsubs1_010100004568
YfiC is an ATP-binding protein component of an uncharacterized ABC transporter in Bacillus subtilis. Similar to other ABC transporters, it likely consists of a nucleotide-binding domain (NBD) that hydrolyzes ATP to energize substrate transport. ABC transporters generally contain two transmembrane domains (TMDs) and two NBDs, with the latter containing conserved motifs including Walker A, Walker B, and signature motifs. Based on structural similarities to characterized ABC transporters like BmrA (YvcC) in B. subtilis, YfiC likely functions as part of a homodimeric or heterodimeric transporter complex .
Unlike some characterized B. subtilis ABC transporters such as BmrA (YvcC), which is constitutively expressed throughout bacterial growth , the expression pattern of YfiC remains largely uncharacterized. Expression analysis would require techniques similar to those used for other B. subtilis genes, including reporter gene fusions, quantitative RT-PCR, or RNA-seq approaches. Based on patterns observed with other ABC transporters, YfiC expression might be regulated by specific environmental conditions or growth phases, although this requires experimental verification.
Understanding the genomic context of yfiC requires:
Genome sequence analysis to identify flanking genes and potential operonic structures
Transcriptional analysis using Northern blotting or RT-PCR to confirm co-transcription with adjacent genes
Promoter mapping using 5' RACE or primer extension
Analysis of transcription factor binding sites similar to the approach used for yciC, where Zur binding sites were identified
The identification of nearby genes may provide functional insights, as ABC transporter genes are often organized in operons with genes encoding cognate permeases or substrate-binding proteins.
Based on characterized ABC transporters like the ATP-binding subunit from Geobacillus kaustophilus, YfiC likely contains:
An ATP-binding pocket with Walker A and B motifs
A signature LSGGQ motif characteristic of ABC transporter NBDs
A thick "L" shape structure with two arms similar to other bacterial ATP-binding subunits
Conserved catalytic residues for ATP hydrolysis
The precise structure would require X-ray crystallography or cryo-EM analysis, similar to the 1.77 Å resolution structure determined for the G. kaustophilus ATP-binding subunit .
To determine YfiC structure:
Express recombinant YfiC with a purification tag (e.g., His6) using B. subtilis constitutive expression systems
Purify using affinity chromatography followed by size-exclusion chromatography
Assess protein homogeneity using dynamic light scattering
Screen crystallization conditions using vapor diffusion methods
Optimize crystal growth for X-ray diffraction studies
Alternatively, employ cryo-EM for structural determination if crystallization proves challenging
The structure could then be compared to known ABC transporter structures to identify unique features of YfiC.
Based on characterized ABC transporters, YfiC likely contains:
| Domain/Motif | Expected Sequence Features | Function |
|---|---|---|
| Walker A motif | GXXGXGKS/T | ATP binding |
| Walker B motif | XXXXD (where X is hydrophobic) | ATP hydrolysis coordination |
| Signature motif | LSGGQ | ABC transporter identification |
| Q-loop | Contains conserved glutamine | Coordinates Mg2+ |
| D-loop | Contains conserved aspartate | Coordinates with Walker A |
| H-loop/switch | Contains conserved histidine | Positions water for ATP hydrolysis |
These motifs would need to be experimentally verified through site-directed mutagenesis and functional assays similar to those conducted for BmrA .
For YfiC expression, researchers should consider:
Homologous expression in B. subtilis using constitutive expression vectors derived from IPTG-inducible systems (with lacI gene deleted)
Heterologous expression in E. coli using lacIq strains for regulated expression by retaining lacOI and lacO3 operator sites
Codon optimization based on the favorable feature that "B. subtilis has no significant bias in codon usage"
The B. subtilis constitutive expression system has demonstrated yields of up to 13% of total cellular protein for other recombinant proteins , making it potentially suitable for YfiC production.
For purification of functional YfiC:
Add a hexahistidine tag to facilitate affinity purification
Use n-dodecyl β-D-maltoside or other mild detergents for membrane protein solubilization (if YfiC shows membrane association)
Employ one-step affinity chromatography using nickel or cobalt resins
Assess protein purity by SDS-PAGE and Western blotting
Verify protein functionality through ATPase activity assays
This approach parallels successful methods used for BmrA purification, which yielded highly pure and functional protein .
To verify YfiC functionality:
Measure ATPase activity using colorimetric phosphate release assays
Assess nucleotide binding through fluorescence spectroscopy using fluorescent ATP analogs
Perform thermal shift assays to evaluate protein stability with and without ATP
Reconstitute purified YfiC into liposomes to evaluate ATP hydrolysis in a membrane environment
Examine ATP binding cooperativity using enzyme kinetics analysis, as BmrA showed positive cooperativity in ATP hydrolysis
Functional YfiC should demonstrate vanadate-sensitive ATPase activity similar to other ABC transporters.
To determine YfiC substrates:
Generate yfiC knockout mutants and assess phenotypic changes in growth under different conditions
Perform transport assays using fluorescent substrates similar to those used for BmrA (Hoechst 33342, doxorubicin, 7-aminoactinomycin D)
Prepare inverted membrane vesicles enriched with overexpressed YfiC to measure substrate transport
Use fluorescence spectroscopy to detect binding of potential substrates
Employ isothermal titration calorimetry to quantify substrate binding affinities
These approaches parallel successful strategies used to characterize BmrA, which was confirmed as a multidrug ABC transporter in B. subtilis .
Given that some B. subtilis ABC transporters are involved in metal homeostasis (e.g., yciC in zinc homeostasis ), researchers should:
Assess yfiC expression changes in response to different metal concentrations
Look for metal-responsive regulatory elements in the yfiC promoter region
Measure intracellular metal content in wild-type versus ΔyfiC strains using ICP-MS
Perform metal binding assays with purified YfiC protein
Test growth of ΔyfiC mutants under metal limitation or excess conditions
The approach used to characterize the Zur-regulated yciC gene provides a methodological template .
To characterize YfiC ATPase function:
Measure ATP hydrolysis rates using purified protein with a malachite green assay
Determine kinetic parameters (Km, Vmax) and substrate specificity
Investigate ATPase activity modulation by potential transport substrates
Assess cooperativity in ATP hydrolysis through Hill coefficient analysis
Examine vanadate sensitivity as a hallmark of ABC transporter ATPase activity
Reconstitute YfiC into liposomes to measure ATPase activity in a membrane-like environment
For context, reconstituted BmrA showed "the highest, vanadate-sensitive, ATPase activity reported so far for an ABC transporter" with positive cooperativity .
Based on known regulatory mechanisms of other B. subtilis ABC transporters:
Look for potential binding sites of known transcriptional regulators (similar to Zur boxes found in the yciC regulatory region)
Perform chromatin immunoprecipitation (ChIP) to identify proteins binding to the yfiC promoter
Use reporter gene fusions to measure yfiC expression under different growth conditions
Analyze the effect of gene knockouts of potential regulatory proteins on yfiC expression
Examine expression patterns in different growth phases and stress conditions
The yciC gene provides an example of complex regulation with two functional Zur boxes: a primary site overlapping a σA promoter and a second site near the translational start point .
While acknowledging limitations of computational methods for functional prediction , researchers should:
Perform phylogenetic analysis of YfiC among Bacillus species
Analyze gene neighborhood conservation across related bacteria
Identify co-expressed genes through transcriptomic data mining
Use domain-based annotation tools while being cautious of paralog over-propagation mistakes
Apply protein structure prediction tools like AlphaFold to generate structural models for comparison with characterized ABC transporters
A comprehensive comparison requires:
Sequence alignment to identify conserved and divergent regions
Structural modeling to compare predicted fold patterns
Expression pattern analysis under identical growth conditions
Functional assays using identical substrates and conditions
Phenotypic analysis of respective gene knockouts
BmrA (YvcC) provides a valuable reference point as a well-characterized B. subtilis ABC transporter that functions as a multidrug transporter with ATP-dependent drug efflux .
The G. kaustophilus ATP-binding subunit structure at 1.77 Å resolution provides valuable insights:
The expected "L" shape with two thick arms characteristic of bacterial ATP-binding subunits
Location of the ATP-binding pocket near the end of arm I
Potential dimerization interface based on crystal structure
Comparison with similar structures from other bacteria (e.g., Salmonella typhimurium)
These structural features likely apply to YfiC given the conservation of ABC transporter nucleotide-binding domains across bacterial species.
To address the challenge that "in vitro activity alone is not sufficient to validate the function of protein in vivo" :
Combine biochemical characterization with genetic studies
Perform complementation assays with the ΔyfiC strain
Use site-directed mutagenesis to create variants with altered ATP binding/hydrolysis
Examine physiological phenotypes under relevant stress conditions
Follow Gene Ontology Consortium definitions to capture both molecular and biological functions
Consider enzyme promiscuity in vitro versus specific biological roles in vivo
This comprehensive approach addresses the scientific best practice that "best practices in functional annotations of enzymes strive to provide both in vitro (biochemical) and in vivo (genetic) evidence" .
Given the limitations of computational predictions highlighted in recent research :
Design experiments to specifically test predicted functions
Use genetic knockouts combined with phenotypic assays under predicted relevant conditions
Perform substrate transport assays with predicted substrates
Express recombinant YfiC and test predicted biochemical activities
Consider the biological context and avoid paralog over-propagation mistakes
Researchers should remember that "for around a quarter of [computational] predictions, the same EC number was already present in the Uniprot annotation" , emphasizing the need for critical evaluation of computational results.